Rubix Life Sciences, a biotech data firm, releases a report based on aggregated data that shows there are health disparities due to racial inequities in the treatment of Black, Indigenous, and People of Color for COVID-19. By looking at recent billing from several states, they are able to track which patients were offered a COVID-19 test and which were not.